All Contraception articles
-
Independent professional body guidelineFSRH CHC guideline
This concise updated summary of the FRSH combined hormonal contraception guideline covers use, effectiveness, non-contraceptive benefits, and risks
-
News
COVID-19 pandemic affecting women’s reproductive health
In a survey conducted in April 2021, women reported disturbances in menstrual cycles and worsening of premenstrual symptoms
-
Independent professional body guideline
FSRH Progestogen-only injectable contraception guideline
Evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables available in the UK
-
Independent professional body guideline
FSRH guidance on incorrect use of combined hormonal contraception
This Guidelines summary guides management for when a woman has made a mistake using combined oral contraceptive pills, combined vaginal ring, and combined transdermal patch
-
Independent professional body guideline
FSRH overweight, obesity, and contraception guideline
Covering evidence-based recommendations on the provision of contraception to women who are overweight or obese
-
News
FSRH says women should always be offered pain relief in IUD procedures
The FSRH has released a statement recommending appropriate analgesia for all IUD fitting procedures
-
News
Contraceptive mini pill being made available over the counter
POPs containing desogestrel will soon be available to buy in pharmacies after a consultation with a pharmacist
-
News
FSRH publishes advice on long-acting reversible contraceptives during COVID-19
During the COVID-19 pandemic, the FSRH has recommended extended use of some long-acting reversible contraceptives.
-
Independent professional body guideline
FSRH progestogen-only implant guideline
A summary of guidance relating to the etonogestrel subdermal contraceptive implant
-
Independent professional body guideline
FSRH emergency contraception guideline
This summary of FSRH EC guidance compares the effectiveness of EC methods and decision-making based on patients’ needs, including helpful algorithms.
-
Independent professional body guideline
FSRH guideline on contraception for women over 40
A summary of guidance for healthcare practitioners working in sexual and reproductive healthcare regarding contraception in women over 40
-
Working party guideline/algorithm
Women of child-bearing age with inflammatory rheumatic diseases guideline
This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.
-
Independent professional body guideline
FSRH UKMEC contraception guideline
A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.
-
Video
Dr Sarah Hardman Q&A on combined hormonal contraception
In this video, taken at Guidelines Live 2019, Dr Sarah Hardman answers questions on the FSRH guideline update on CHC, the key elements of CHC, factors influencing a patient’s choice of contraception, and her key take home messages
-
Independent professional body guideline
FSRH intrauterine contraception guideline
This concise summary of guidance on intrauterine contraception (IUC) includes efficacy, insertion, duration of use, risks, benefits, and complications.
-
NICE guideline
NICE LARC guideline
This guideline covers important points to raise with women that may benefit from long-acting reversible contraception
-
Test and reflect
FSRH guideline on emergency contraception
This CPD activity consists of 7 multiple-choice questions designed to test your knowledge on emergency contraception.
-
Test and reflect
Appropriate choice of long-acting reversible contraception in primary care
This management algorithm was developed by a multidisciplinary expert panel: Connolly et al with the support of a grant from a pharmaceutical company
-
Feature article
UKMEC supports the delivery of safe, evidence-based contraceptive care
Shelley Raine explains why the UKMEC is so important in general practice and how to apply the recommendations when seeing women, both for the initiation of a contraceptive method and continuation of a treatment.
